Cargando…
Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy
KRAS is the most commonly mutated oncogene in human cancers and is associated with poor prognosis and drug resistance. Let-7 is a family of tumor suppressor microRNAs that are frequently suppressed in solid tumors, where KRAS mutations are highly prevalent. In this study, we investigated the potenti...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422443/ https://www.ncbi.nlm.nih.gov/pubmed/25946136 http://dx.doi.org/10.1371/journal.pone.0126653 |